Pages that link to "Q34754716"
Jump to navigation
Jump to search
The following pages link to Large-scale chemical dissection of mitochondrial function (Q34754716):
Displaying 50 items.
- The CRIT framework for identifying cross patterns in systems biology and application to chemogenomics (Q21184023) (← links)
- Molecular aspects of thyroid hormone actions (Q22306217) (← links)
- The β2-adrenoceptor agonist formoterol stimulates mitochondrial biogenesis (Q24598253) (← links)
- Predicting new molecular targets for known drugs (Q24649687) (← links)
- Is immunity a mechanism contributing to statin-induced diabetes? (Q26785561) (← links)
- Mitochondrial targets for pharmacological intervention in human disease (Q26824514) (← links)
- Cardiovascular Disease, Mitochondria, and Traditional Chinese Medicine (Q26830261) (← links)
- Powering the immune system: mitochondria in immune function and deficiency (Q26853485) (← links)
- Strategic applications of gene expression: from drug discovery/development to bedside (Q26864172) (← links)
- Modulation of h(2)s metabolism by statins: a new aspect of cardiovascular pharmacology (Q27001076) (← links)
- A Dormant Microbial Component in the Development of Preeclampsia (Q28069689) (← links)
- Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases (Q28388335) (← links)
- Polymorphisms in the mitochondrial ribosome recycling factor EF-G2mt/MEF2 compromise cell respiratory function and increase atorvastatin toxicity (Q28480419) (← links)
- A chemical screen probing the relationship between mitochondrial content and cell size (Q28481860) (← links)
- Differential mitochondrial toxicity screening and multi-parametric data analysis (Q28484406) (← links)
- A simple high-content cell cycle assay reveals frequent discrepancies between cell number and ATP and MTS proliferation assays (Q28488243) (← links)
- TRPV4 is a regulator of adipose oxidative metabolism, inflammation, and energy homeostasis (Q28586703) (← links)
- Chemical approaches to nuclear receptors in metabolism (Q30353963) (← links)
- Common variants within oxidative phosphorylation genes influence risk of ischemic stroke and intracerebral hemorrhage (Q30414654) (← links)
- Causal effects of synthetic chemicals on mitochondrial deficits and diabetes pandemic (Q30426889) (← links)
- Connecting synthetic chemistry decisions to cell and genome biology using small-molecule phenotypic profiling (Q33510297) (← links)
- High-throughput assay for modulators of mitochondrial membrane potential identifies a novel compound with beneficial effects on db/db mice (Q33556580) (← links)
- Estrogen: a master regulator of bioenergetic systems in the brain and body (Q33623924) (← links)
- ERRgamma regulates cardiac, gastric, and renal potassium homeostasis (Q33634214) (← links)
- miR-24-mediated knockdown of H2AX damages mitochondria and the insulin signaling pathway (Q33646200) (← links)
- A method to identify and validate mitochondrial modulators using mammalian cells and the worm C. elegans (Q33749557) (← links)
- Generalized Theorems for Nonlinear State Space Reconstruction (Q33869792) (← links)
- F1F0-ATP synthases of alkaliphilic bacteria: lessons from their adaptations (Q33931346) (← links)
- Role of systems pharmacology in understanding drug adverse events (Q34134791) (← links)
- Evaluation of skeletal muscle during calf exercise by 31‐phosphorus magnetic resonance spectroscopy in patients on statin medications (Q34155702) (← links)
- Detecting causality in complex ecosystems (Q34300961) (← links)
- Estrogen regulation of glucose metabolism and mitochondrial function: therapeutic implications for prevention of Alzheimer's disease (Q34360055) (← links)
- Discovery of small-molecule enhancers of reactive oxygen species that are nontoxic or cause genotype-selective cell death. (Q34616049) (← links)
- Statins and pulmonary fibrosis: the potential role of NLRP3 inflammasome activation (Q34635121) (← links)
- Finding novel pharmaceuticals in the systems biology era using multiple effective drug targets, phenotypic screening and knowledge of transporters: where drug discovery went wrong and how to fix it. (Q34646772) (← links)
- Integrating phenotypic small-molecule profiling and human genetics: the next phase in drug discovery (Q34797680) (← links)
- Antihelminthic benzimidazoles are novel HIF activators that prevent oxidative neuronal death via binding to tubulin. (Q34802673) (← links)
- Screen for small molecules increasing the mitochondrial membrane potential (Q34836339) (← links)
- Functional genomic analysis of human mitochondrial RNA processing (Q34893567) (← links)
- A modern approach to the treatment of mitochondrial disease (Q35011397) (← links)
- Connecting Small Molecules with Similar Assay Performance Profiles Leads to New Biological Hypotheses (Q35086163) (← links)
- Genetic variation of oxidative phosphorylation genes in stroke and Alzheimer's disease (Q35086253) (← links)
- Nutrient-sensitized screening for drugs that shift energy metabolism from mitochondrial respiration to glycolysis (Q35101307) (← links)
- High-throughput screening of FDA-approved drugs using oxygen biosensor plates reveals secondary mitofunctional effects (Q35208534) (← links)
- A small-molecule screening strategy to identify suppressors of statin myopathy (Q35223789) (← links)
- Differential programming of p53-deficient embryonic cells during rotenone block. (Q35626028) (← links)
- Energetics, epigenetics, mitochondrial genetics (Q35632855) (← links)
- Genetic and proteomic approaches to identify cancer drug targets (Q35683353) (← links)
- Endothelial protective genes induced by statin are mimicked by ERK5 activation as triggered by a drug combination of FTI-277 and GGTI-298. (Q35736398) (← links)
- Predicting new indications for approved drugs using a proteochemometric method (Q36165369) (← links)